Last updated: August 06, 2026

Application No. 18/285,918

PERFORMANCE-ENHANCING EXCIPIENTS AND METHODS OF REDUCING VISCOSITY AND INCREASING STABILITY OF BIOLOGIC FORMULATIONS

Non-Final OA

Filed

Oct 06, 2023

Priority

Apr 09, 2021 — provisional 63/173,055 +1 more

Examiner

TRUONG, QUANGLONG N

Art Unit

1615

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Avantor Performance Materials, LLC

OA Round

2 (Non-Final)

Interview Optional

— +23.5% interview lift. Examiner has a relatively high allowance rate (79%); +23.5% interview lift. A written response may suffice.

Based on 646 resolved cases, 2023–2026

Examiner Intelligence

TRUONG, QUANGLONG N View full profile →

Grants 79% — above average

Career Allowance Rate

509 granted / 646 resolved

+18.8% vs TC avg

Strong +24% interview lift

Without

With

+23.5%

Interview Lift

resolved cases with interview

Typical timeline

2y 2m

Avg Prosecution

48 currently pending

Career history

683

Total Applications

across all art units

Statute-Specific Performance

§101

4.1%

-35.9% vs TC avg

§103

55.1%

+15.1% vs TC avg

§102

11.3%

-28.7% vs TC avg

§112

18.4%

-21.6% vs TC avg

Black line = Tech Center average estimate • Based on career data from 646 resolved cases

Prosecution Timeline

Oct 06, 2023

Application Filed

Oct 31, 2025

Non-Final Rejection mailed

Apr 30, 2026

Response Filed

Jul 27, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/552,013

Patent 12691055

INCRETIN ANALOG-CONTAINING COMPOSITIONS AND USES THEREOF

2y 10m to grant Granted Jul 28, 2026

17/759,310

Patent 12678387

COMPOSITION FOR ALLEVIATING HAIR LOSS OR PROMOTING HAIR GROWTH

3y 11m to grant Granted Jul 14, 2026

18/568,019

Patent 12678411

Nanoformulations of Pazopanib, Compositions Comprising the Same and Methods of Treating Osteoarthritis

2y 7m to grant Granted Jul 14, 2026

18/449,021

Patent 12673017

ULTRA-MILD, CONCENTRATED AND SELF-PRESERVING CLEANSING COMPOSITIONS FOR PERSONAL CARE

2y 10m to grant Granted Jul 07, 2026

18/560,955

Patent 12673023

MEDICINE CONTAINER COMPRISING LIQUID PHARMACEUTICAL COMPOSITION OF 1-(5-(2,4-DIFLUOROPHENYL)-1-((3-FLUOROPHENYL)SULFONYL)-4-METHOXY-1H-PYRROL-3-YL)-N-METHYLMETHANAMINE

2y 7m to grant Granted Jul 07, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

2-3

Expected OA Rounds

79%

Grant Probability

99%

With Interview (+23.5%)

2y 2m (~0m remaining)

Median Time to Grant

Moderate

PTA Risk

Based on 646 resolved cases by this examiner. Grant probability derived from career allowance rate.